Showing results (291-300 of 337) with videos related to

Sort By:
Pageof 34
Journal of Experimental Psychology. General|November 12, 2020
Interoceptive cardiac signals selectively enhance fear memoriesSarah N Garfinkel, Cassandra D Gould van Praag, Miriam Engels, et al.
Plos One|September 28, 2013
Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseasesValeriy Duka, Jae-Hoon Lee, Joel Credle, et al.
Journal of Renal Care|August 18, 2017
Urea-based recirculation validation of the symmetrical palindrome catheterMartin Jonczyk, Christian Althoff, Torsten Slowinski, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 22, 2024
Implicating the cholecystokinin B receptor in liver stem cell oncogenesisMartha D Gay, Jack C Drda, Wenqiang Chen, et al.
International Angiology : a Journal of the International Union of Angiology|October 27, 2015
Ethylene-vinyl alcohol polymer trans-arterial embolization in emergency peripheral active bleeding: initial experienceA M Ierardi, G Xhepa, E Duka, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 24, 2012
Withdrawal-associated increases and decreases in functional neural connectivity associated with altered emotional regulation in alcoholismOwen G O'Daly, Leanne Trick, Jess Scaife, et al.
Nuclear Medicine Communications|August 23, 2020
123I-Ioflupane dopamine transporter imaging (DaTSCAN) appearances in relation to emotional responsiveness, impulsivity and olfaction in suspected Parkinsonian syndromeGuglielmo La Torre, Aleksandra Maria Herman, Maryam Jessop, et al.
Pilot and Feasibility Studies|July 30, 2021
A feasibility trial of an intervention in alcohol dependence for structured preparation before detoxification versus usual care: the SPADe trial resultsChristos Kouimtsidis, Ben Houghton, Heather Gage, et al.
International Journal of Molecular Sciences|February 25, 2023
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular CarcinomaNarayan Shivapurkar, Martha D Gay, Aiwu Ruth He, et al.
Chemmedchem|August 8, 2006
Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation and decrease alpha-synuclein protein expression in a cellular model of Parkinson's diseaseAlan P Kozikowski, Irina N Gaisina, Pavel A Petukhov, et al.
Pageof 34